Monthly News Roundup – September 2020
Genentech’s Gavreto Cleared for RET Fusion-Positive NSCLC Gavreto (pralsetinib) is a RET kinase inhibitor used for the treatment of adults
Read more
Monthly Vitamin D Supplement May Not Cut Cancer Risk
MONDAY, July 23, 2018 — Monthly high-dose vitamin D supplementation may not prevent the risk of cancer among adults aged
Read more